Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing

被引:57
作者
Gratchev, A [1 ]
Schledzewski, K [1 ]
Guillot, P [1 ]
Goerdt, S [1 ]
机构
[1] Univ Heidelberg, Med Ctr Mannheim, Dept Dermatol, D-6800 Mannheim, Germany
来源
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY | 2001年 / 14卷 / 05期
关键词
antigen-presenting cell polarization; alternatively activated macrophages; immature myeloid dendritic cells; lymphoid dendritic cells; tolerance; downregulation of inflammation; induction of Th2;
D O I
10.1159/000056357
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The Th1/Th2 paradigm has stimulated extensive research into the mechanisms underlying T-cell polarization; alternative activation of antigen-presenting cells (APCs) has turned out to be the corresponding concept APC polarization. Macrophages (M phi) as well as dendritic cells (DCs) can undergo Th1- or Th2-like polarization; APC1 and APC2 thus acquire the capacity to drive the development of naive T cells and the reactivation of resting T cells towards either a Th1 or a Th2 phenotype, respectively. Among polarized APC, effector macrophages are classically activated by mediators such as IFN-gamma, TNF-alpha or LPS (M phi1), while M phi2 are alternatively activated by IL-4, IL-10 or PGE(2). M phi2 exhibit a unique molecular repertoire including receptors of innate immunity with broad specificity for foreign antigen and anti-inflammatory cytokines such as IL-1 receptor antagonist and alternative macrophage activation-associated CC-chemokine (AMAC)-1. While DC1 are well characterized, contradictory results have been obtained for DC2 that may either represent immature myeloid DCs or lymphoid DCs. Altogether, APC2 have come to age; they mediate Th2 differentiation, tolerance induction, downregulation of inflammation and healing. Thus, APC2 represent a hitherto neglected, but indispensable major pathway of APC activation and function. Copyright (C) 2001 S. KargerAG, Basel.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 50 条
[21]   Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype [J].
Hilkens, CMU ;
Kalinski, P ;
deBoer, M ;
Kapsenberg, ML .
BLOOD, 1997, 90 (05) :1920-1926
[22]  
Hilkens CMU, 1996, J IMMUNOL, V156, P1722
[23]  
Högger P, 1998, J IMMUNOL, V161, P1883
[24]   Langerhans cells do not express alternative macrophage activation-associated CC chemokine (AMAC)-1 [J].
Kodelja, V ;
Kraft, S ;
Politz, O ;
Hakij, N ;
Treudler, R ;
Orfanos, CE ;
Bieber, T ;
Goerdt, S .
RESEARCH IN IMMUNOLOGY, 1998, 149 (7-8) :633-637
[25]   Differences in angiogenic potential of classically vs alternatively activated macro phages [J].
Kodelja, V ;
Muller, C ;
Tenorio, S ;
Schebesch, C ;
Orfanos, CE ;
Goerdt, S .
IMMUNOBIOLOGY, 1997, 197 (05) :478-493
[26]  
Kodelja V, 1998, J IMMUNOL, V160, P1411
[27]  
Kohrgruber N, 1999, J IMMUNOL, V163, P3250
[28]  
Liu LM, 1997, ADV EXP MED BIOL, V417, P375
[29]  
MACATONIA SE, 1995, J IMMUNOL, V154, P5071
[30]   TREATMENT OF MURINE MACROPHAGES WITH INTERFERON-GAMMA INHIBITS THEIR ABILITY TO BIND LEISHMANIA PROMASTIGOTES [J].
MOSSER, DM ;
HANDMAN, E .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 52 (04) :369-376